Dow Jones Losers Today: NIKE and UnitedHealth Lead Declines
Dow Jones losers in today's session were led by NIKE and UnitedHealth, with all ten decliners down between 2.21% and 5.77%.
Read more
Historical closes from the market data provider. Adjusted for splits; corporate actions can affect comparability across periods.
Metrics supplied by the company data provider. Trailing-twelve-month figures update when the provider refreshes its dataset.
Fiscal years 2022, 2023, 2024, 2025. All figures in USD. Values are as reported by the company.
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total revenue | $59.28B | $60.12B | $64.17B | $65.01B |
| Gross profit | $41.87B | $43.99B | $48.98B | $48.63B |
| Operating income | $18.28B | $2.95B | $20.22B | $22.11B |
| Net income | $14.52B | $365.00M | $17.12B | $18.25B |
| Diluted EPS | 5.71 | 0.14 | 6.74 | 7.28 |
| Total assets | $109.16B | $106.68B | $117.11B | $136.87B |
| Shareholders' equity | $45.99B | $37.58B | $46.31B | $52.61B |
| Operating cash flow | $19.10B | $13.01B | $21.47B | $16.47B |
| Free cash flow | $14.71B | $9.14B | $18.10B | $12.36B |
Annual statements sourced from the market data provider. Companies with different fiscal year ends are not directly comparable on a calendar basis.
| Ex-date | Amount per share |
|---|---|
| 15 Sep 2026 | $0.8500 |
| 15 Jun 2026 | $0.8500 |
| 16 Mar 2026 | $0.8500 |
| 15 Dec 2025 | $0.8500 |
| 15 Sep 2025 | $0.8100 |
| 16 Jun 2025 | $0.8100 |
| 17 Mar 2025 | $0.8100 |
| 16 Dec 2024 | $0.8100 |
| 16 Sep 2024 | $0.7700 |
| 17 Jun 2024 | $0.7700 |
| 14 Mar 2024 | $0.7700 |
| 14 Dec 2023 | $0.7700 |
| 14 Sep 2023 | $0.7300 |
| 14 Jun 2023 | $0.7300 |
| 14 Mar 2023 | $0.7300 |
| 14 Dec 2022 | $0.7300 |
| 14 Sep 2022 | $0.6900 |
| 14 Jun 2022 | $0.6900 |
| 14 Mar 2022 | $0.6900 |
| 14 Dec 2021 | $0.6900 |
Amounts are as declared and are not adjusted for withholding tax. Dividend policy can change at any time.
| Period | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| 2026-09-30 · Q3 2026 | 2.10 | 2.49 | +18.46% |
| 2026-06-30 · Q2 2026 | -0.27 | -0.13 | +52.33% |
| 2026-03-31 · Q1 2026 | -1.52 | -1.28 | +16.00% |
| 2025-12-31 · Q4 2025 | 2.03 | 2.09 | +2.98% |
Estimates are consensus figures collected by the data provider. Reported values can be restated after publication.
Dow Jones losers in today's session were led by NIKE and UnitedHealth, with all ten decliners down between 2.21% and 5.77%.
Read more
Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index falling 2.1% and the S
Read more
Dow Jones decliners in today's session include UnitedHealth, Nike, Caterpillar, Merck, Visa, Coca-Cola, Goldman Sachs, Honeywell and Johnson & Johnson, dow...
Read more
MRNA's ambitious oncology investments and expanding vaccine portfolio drive growth, but rising costs and uncertain revenues test its financial recovery.
Read more
Halozyme said it would immediately file a patent infringement lawsuit against Merck in Germany, seeking permanent relief
Read more
Today's big story: Could Anthropic Stock Fall 25.
Read more
Halozyme Therapeutics, Inc. (Nasdaq: HALO) (Halozyme), today provided an update on the German preliminary injunction hearing that overturned the decision i...
Read more
Zacks highlights Merck, Caterpillar, Union Pacific, Daily Journal and Community Bancorp, examining growth drivers, competitive pressures and key investment...
Read more
Merck & Co. (NYSE:MRK) has entered into a research collaboration with Isomorphic Labs to identify and develop potential small-molecule cancer treatments us...
Read more
Merck & Co., Inc. (NYSE:MRK) is studying how its experimental personalized cancer vaccine might work across different tumor types, with kidney cancer data...
Read moreHeadlines and summaries are supplied by third-party news providers. Links open the original publisher. Inclusion does not imply endorsement.
Add the app to your home screen for faster access to market data.
Use Google Chrome on your Android phone or tablet. Other Chromium browsers such as Edge or Samsung Internet work too.
Tap the three-dot menu in the top-right corner of the browser.
Select Install app or Add to Home screen from the menu.
Tap Install in the prompt. The Expert Options View icon appears on your home screen and app drawer.
On iPhone or iPad, installation only works in Safari. Open this page in Safari rather than Chrome or Firefox.
Tap the Share icon in the toolbar at the bottom of the screen.
Swipe down the share sheet and tap Add to Home Screen.
Confirm with Add in the top-right corner. The app icon is added to your home screen and opens full screen.
The app is free, takes no extra storage beyond a small cache, and works on Android and iOS. No app store account is needed.